2020
DOI: 10.1111/ggi.13997
|View full text |Cite
|
Sign up to set email alerts
|

Is sarcopenia primarily an age‐related or renin–angiotensin system‐related disorder?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 7 publications
0
3
0
Order By: Relevance
“…In light of the aforementioned data, it is paramount to consider RAS-related disorders (Table SI 1 ) ( 65 79 ) in the diagnosis and management of sarcopenia ( 80 ). The association between sarcopenia and hypertension also needs to be better understood ( 81 ). Among 99 variables, age, systolic arterial hypertension, mini-nutritional assessment, number of chronic diseases, and blood sodium level were found to be independent determinants of sarcopenia ( 82 ).…”
Section: Pathophysiology Of Sarcopeniamentioning
confidence: 99%
“…In light of the aforementioned data, it is paramount to consider RAS-related disorders (Table SI 1 ) ( 65 79 ) in the diagnosis and management of sarcopenia ( 80 ). The association between sarcopenia and hypertension also needs to be better understood ( 81 ). Among 99 variables, age, systolic arterial hypertension, mini-nutritional assessment, number of chronic diseases, and blood sodium level were found to be independent determinants of sarcopenia ( 82 ).…”
Section: Pathophysiology Of Sarcopeniamentioning
confidence: 99%
“…Drugs can also play a protective or causative role in the development of sarcopenia. Statins, sulfonylureas, glinides have a potential harmful effect on muscle metabolism; while ACE inhibitors, allopurinol, Vitamin D play a protective role on muscle function [45,46]. The muscle is formed of different types of muscle fibers: slow fibers (type I) and fast fibers (types IIa and IIb).…”
Section: Sarcopenia As Biological Substrate Of Physical Frailtymentioning
confidence: 99%
“…Although statistically insignificant (due to the small sample size), all non-survivors were overweight or obese, and the prevalence of chronic comorbidities was about two times more common in the non-survivors. As sarcopenia is primarily an age- and renin angiotensin system-related disorder (like hypertension, obesity, diabetes mellitus, and metabolic syndrome) ( 2 ); having older ages and chronic disease(s) of non-survivors might have led to sarcopenic obesity and indeed to mortality in COVID-19 ( 3 ). Yet, it is known that obesity and sarcopenia act synergistically to increase the risk of disability ( 4 ), and sarcopenic obesity was found to be an independent risk factor for mortality in the intensive care unit ( 5 ).…”
mentioning
confidence: 99%